Dr. Anthony B. Pinkerton trained as a synthetic organic chemist in the laboratories of Dieter Seebach (ETH-Zurich) and Barry Trost (Stanford University). His industry career began at Merck Research Laboratories (San Diego). Over his career Dr. Pinkerton has worked in multiple areas including CNS, virology, diabetes, inflammation, and oncology, with extensive experience in G protein-coupled receptors. He has been both project leader and project manager, as well as chemistry lead for the metabolic disease team, where he helped identify and prosecute the most promising new targets in the field. He has performed due diligence for in-licensing efforts and competitive intelligence for multiple targets, in addition to developing IP strategies around multiple chemical series. In addition to numerous publications, Dr. Pinkerton is inventor/co-inventor on 40+ patents or patent applications covering small-molecule therapeutics. He has helped advance five compounds into clinical development.